Document is current
Any future updates will be listed below
-
Authors
Moreno-García, Sara https://orcid.org/0009-0005-9317-3676
González-Recio, Paule https://orcid.org/0000-0002-0707-0066
Donat, Marta https://orcid.org/0000-0002-6323-2779
Iniesta, Carlos https://orcid.org/0000-0002-0928-2679
Folch, Cinta https://orcid.org/0000-0001-8400-2668
Alonso-Colón, María https://orcid.org/0000-0001-6542-4590
Guerras, Juan Miguel https://orcid.org/0000-0001-6708-3291
Belza, María José https://orcid.org/0000-0003-4816-7750
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI22/00018)
Instituto de Salud Carlos III (PI22/00018)
Instituto de Salud Carlos III (PI22/00018)
Plan Nacional sobre Drogas (EXP2022/008906)
Plan Nacional sobre Drogas (EXP2022/008906)
Plan Nacional sobre Drogas (EXP2022/008906)
- License Information
-
More Information
Article History
Received: 18 March 2025
Accepted: 1 July 2025
First Online: 7 July 2025
Declarations
:
: All people gave their informed consent voluntarily and did not receive any type of economic incentive. The questionnaire ensured anonymity and confidentiality by not collecting identifying data. The study was approved by the Research Ethics Committee of the Carlos III Health Institute (CEI PI 44_2023-v3).
: The authors declare no competing interests.
